-
1 Comment
Northeast Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 1.5% below its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Northeast Pharmaceutical Group Co., Ltd's total revenue sank by 12.6% to $2B since the same quarter in the previous year.
Its net income has increased by 938.9% to $11M since the same quarter in the previous year.
Finally, its free cash flow fell by 87.5% to $59M since the same quarter in the previous year.
Based on the above factors, Northeast Pharmaceutical Group Co., Ltd gets an overall score of 2/5.
CurrencyCode | CNY |
---|---|
Exchange | SHE |
ISIN | CNE0000009G0 |
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
Dividend Yield | 0.2% |
---|---|
Market Cap | 8B |
PE Ratio | 23.2 |
Beta | 0.23 |
Target Price | None |
Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products; API products comprising fosfomycin, anti-aids, and other products; and chemical products, including chemical and pharmaceutical intermediates, chiral separation reagent products, etc. The company also provides digestives, narcotic medicines, cardiovascular, cerebrovascular medicines, etc. In addition, it engages in medical distribution business. Northeast Pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Shenyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000597.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024